Salivary Biology & Immunology Program

The Salivary Biology and Immunology Program encourages basic and translational research that:
  • furthers our understanding of the biology of saliva and salivary gland, immunology of oral diseases, and oral manifestations of systemic and infectious diseases
  • develops new tools and technologies to address challenges in these areas
  • explores pathways toward commercialization and therapeutics

Staff Contacts

Funding Opportunity Announcements

Title Staff Contact Opportunity Number Activity Code Expiration Date
Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R21 Clinical Trial Not Allowed) PAR-19-173 R21
Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R01 Clinical Trial Not Allowed) PAR-19-172 R01
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) PAR-19-134 R15
NIH Research Evaluation and Commercialization Hub (REACH) Awards (U01 Clinical Trial Not Allowed) RFA-OD-19-014 U01
NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required) PA-19-092 R21
NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) PA-19-091 R01
Limited Competition: Restoring Research Resources Lost or Damaged Due to Hurricanes Harvey, Irma, and Maria (R24 Clinical Trial Optional) RFA-OD-18-102 R24
NIH Administrative Supplements to Recover Losses Due to Hurricanes Harvey, Irma, and Maria Under the Bipartisan Budget Act of 2018 Non-Construction (Admin Supp Clinical Trial Optional) PA-18-936 D43, D71, DP1
NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed) RFA-DE-19-005 D71, R35
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) PA-18-906 C06, D43, D71
Advancing Extracellular RNA (exRNA) Communication Research: Improved Isolation and Analysis of exRNA-Carrier Subclasses (UG3/UH3 Clinical Trial Not Allowed) RFA-RM-18-027 UG3, UH3
Limited Competition: Data Management and Resource Repository (DMRR) on Extracellular RNA (U54 Clinical Trial Not Allowed) RFA-RM-18-026 D71, U54
Innovative Technologies to Non-Invasively Monitor Genome Edited Cells In Vivo (UH2/UH3 Clinical Trial Not Allowed) RFA-RM-18-025 D71, UG3, UH3
Expanding the Human Genome Engineering Repertoire (U01 Clinical Trial Not Allowed) RFA-RM-18-024 D71, U01
Innovative Technologies to Deliver Genome Editing Machinery to Disease-relevant Cells and Tissues (UG3/UH3 Clinical Trial Not Allowed) RFA-RM-18-023 UG3, UH3
Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed) PA-18-837 R41, R42, R43
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-18-591 C06, D43, D71
Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-18-591 C06, D43, D71
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional) PA-18-739 R21
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional) PA-18-738 R01
Administrative Supplement for Research on Sex/Gender Influences (Admin Supp - Clinical Trial Optional) PA-19-165 DP1, DP2, DP4
PHS 2018-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) PA-18-575 R41, R42
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) PA-18-574 R43, R44
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) PA-18-648 R13
Administrative Supplements for Research on Dietary Supplements (Admin Supp) PA-18-817 P30, P40, P50
Zika Virus (ZIKV) Complications (R21 Clinical Trial Optional) PA-18-048 R21
Academic Research Enhancement Award (Parent R15 Clinical Trial Not Allowed) PA-18-504 R15
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) PA-18-484 R01
Biology Of Aging Dental, Oral And Craniofacial Tissues (R21 - Clinical Trial Not Allowed) RFA-DE-18-010 R21
Biology Of Aging Dental, Oral And Craniofacial Tissues (R01 - Clinical Trial Not Allowed) RFA-DE-18-009 R01
New Technologies for the Glycosciences (R43/R44) PA-16-157 R43, R44
New Technologies for the Glycosciences (R41/R42) PA-16-158 R41, R42
Tools for Cell Line Identification (R43/R44) PA-16-186 R43, R44
NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03) PAR-15-344 R03
Change of Grantee Organization (Type 7 Parent) PA-18-590 C06, D43, D71
Successor-in-Interest (Type 6 Parent) PA-16-286 C06, D43, D71
SBIR Technology Transfer (R43/R44) PA-15-354 R43, R44
Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (R43/R44) PA-16-180 R43, R44
Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (R41/R42) PA-16-181 R41, R42
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44) PA-17-147 R43, R44
Immune System Plasticity in the Pathogenesis and Treatment of Complex Dental, Oral, and Craniofacial Diseases (R01) PAR-15-192 R01
Immune System Plasticity in the Pathogenesis and Treatment of Complex Dental, Oral, and Craniofacial Diseases (R21) PAR-15-193 R21
Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R01) PA-16-295 R01
Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R21) PA-16-296 R21